AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
2
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
3
Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Prompt Security raises $18 million Series A to protect enterprises from GenAI risks
More news

Biopharmaceuticals

3 stories about Biopharmaceuticals
Amotz Shemi Silenseed

Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary

05.10.21|James Spiro
Proceeds from the investment are expected to provide Silenseed with liquidity to fund the company’s Phase III clinical trial
ירון פרג מנכל כאהר מדיקל

Cancer Treatment Company KAHR Medical Raises $18 Million

25.02.20|CTech
The company intends to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107, tested for the treatment of solid tumors
חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer
As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials